Press Releases

 
Press Releases
Date Title/Summary View
Oct 25, 2016 LAWRENCE, Mass., Oct. 25, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that six comprehensive clinical reviews describing the benefits of more frequent hemodialysis were published in the American Journal of Kidney Diseases (AJKD). The rese...
Oct 21, 2016 LAWRENCE, Mass., Oct. 21, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that it is participating in the Partners Healthcare Connected Health Symposium and Expo today, Friday, October 21, 2016 in Boston, MA.  More specifically, NxStage is showcasing re...
Oct 6, 2016 LAWRENCE, Mass., Oct. 6, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced plans to release its financial results for the third quarter ended September 30, 2016, on Thursday, November 3, 2016, before the opening of the financial markets. NxStag...
Oct 3, 2016 LAWRENCE, Mass., Oct. 3, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced a three-year agreement with Satellite Healthcare that includes NxStage's innovative Nx2me Connected Health® platform for their patients performing home hemodialysis ("HHD") th...
Aug 8, 2016 LAWRENCE, Mass., Aug. 8, 2016 NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, today announced the release of new enhanced priming features, the first of many upcoming capabilities of its next generation hemodialysis system.  The features are designed to be used for home treatments with current and next generations...
Aug 4, 2016 LAWRENCE, Mass., Aug. 4, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today reported second quarter revenue above the top end of its guidance. Total revenue for the second quarter of 2016 increased 15 percent to $92.2 million, compared with revenue of $8...
Aug 2, 2016 LAWRENCE, Mass., Aug. 2, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer, and Matthew Towse, Chief Financial Officer, will present at the Canaccord Genuity 36th Annual Growth Conference on Wednesday, Augu...
Jul 21, 2016 LAWRENCE, Mass., July 21, 2016 /PRNewswire/ -- NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is pleased to announce the grand opening of its Macon dialysis center, known as Georgia Kidney Institute ("GKI"). "We aim to give patients their autonomy back by providing treatment options to meet each patient'...
Jul 1, 2016 LAWRENCE, Mass., July 1, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced plans to release its financial results for the second quarter ended June 30, 2016, on Thursday, August 4, 2016, before the opening of the financial markets. NxStage will...
May 24, 2016 LAWRENCE, Mass., May 24, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer, plans to participate in the following schedule of investor conferences. Where applicable, a webcast of the event will be made avai...
Page: FirstPrevious
2
... NextLast
= add release to Briefcase